Travere Therapeutics Stock Forecast

Buy candidate since Aug 05, 2026 Loss -2.98%

The Travere Therapeutics, Inc. stock price fell by -0.701% on the last day (Monday, 10th Aug 2026) from $61.32 to $60.89. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.23% from a day low at $60.61 to a day high of $62.57. The price has fallen in 7 of the last 10 days but is still up by 7.43% over the past 2 weeks. Volume has increased on the last day by 597 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $107.45 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 40.19% during the next 3 months and, with a 90% probability hold a price between $79.14 and $89.22 at the end of this 3-month period.

TVTX Signals & Forecast

The Travere Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $59.19 and $57.37. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, August 05, 2026, and so far it has fallen -2.98%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock

Travere Therapeutics, Inc. finds support from accumulated volume at $58.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.96 between high and low, or 3.23%. For the last week, the stock has had daily average volatility of 5.35%.

Our recommended stop-loss: $58.60 (-3.75%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (TVTX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Travere Therapeutics, Inc. to open at $61.36, and during the day (based on 14 day Average True Range), to move between $59.46 and $62.32, which gives a possible trading interval of +/-$2.85 (+/-4.80%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $61.32 (0.71%) than the support at $58.85 (3.35%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Travere Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Travere Therapeutics, Inc. stock to perform well in the short-term.

Current score: 3.684 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $61.36 ( 0.766%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk